GLP-1 Drugs Covered by Medicare in 2026: Ozempic, Wegovy, Mounjaro & More
Medicare covers GLP-1 drugs for type 2 diabetes — Ozempic and Mounjaro are covered under Part D. Wegovy is now covered for patients with cardiovascular disease following the 2024 SELECT trial results. Weight loss alone is not a covered indication. The 2026 Part D out-of-pocket cap is $2,000.








